Avigen provides outsourced R&D services that support the full development cycle of biologics, cell and gene therapies, and related platforms. Its offerings include target validation, custom assay development, GLP‑compliant pre‑clinical studies, process scale‑up, and regulatory consulting, all delivered through an integrated data management system to accelerate milestones and reduce the need for internal infrastructure.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BBFounders
Product
Problem
Biopharmaceutical companies often lack in‑house expertise and resources to efficiently design, develop, and validate complex biologics and gene‑therapy products, leading to prolonged timelines and higher costs.
Solution
Avigen offers a suite of outsourced R&D services that support the end‑to‑end development of biologics, cell and gene therapies, and advanced therapeutic platforms. Their capabilities include target identification, assay development, pre‑clinical safety testing, and manufacturing process optimization. By leveraging proprietary platforms and a network of specialized laboratories, Avigen accelerates project milestones while maintaining regulatory compliance. Clients receive detailed data packages and technical reports that integrate seamlessly into their internal development pipelines, reducing the need for extensive internal infrastructure.
Target Audience
Primary customers are pharmaceutical and biotech companies developing biologics, cell therapies, or gene‑editing products, as well as academic research groups seeking outsourced development expertise.
Features
- Target validation and biomarker discovery using high‑throughput screening and omics technologies
- Custom assay development and validation for biologics and gene‑editing tools
- In‑vitro and in‑vivo pre‑clinical safety and efficacy studies with GLP‑compliant reporting
- Process development and scale‑up support for cell culture, viral vector production, and purification
- Regulatory consulting and dossier preparation aligned with EMA and FDA requirements
- Integrated data management platform providing real‑time project tracking and secure data sharing